| 1. | | Recruiting | 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia; secondary acute myeloid leukemia |
| 2. | | Recruiting | 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction
Conditions: recurrent esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus |
| 3. | | No longer recruiting | 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Conditions: recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ... |
| 4. | | Completed | Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus
Conditions: recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; ... |
| 5. | | No longer recruiting | Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine
Conditions: recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; ... |
| 6. | | No longer recruiting | Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
Condition: Recurrent Small Cell Lung Cancer |
| 7. | | Recruiting | Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Condition: Head and Neck Cancer |
| 8. | | Recruiting | Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ... |
| 9. | | No longer recruiting | Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer
Conditions: stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 10. | | Recruiting | Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Condition: Head and Neck Cancer |
| 11. | | Recruiting | Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
Conditions: stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer |
| 12. | | Recruiting | BMS-247550 in Treating Patients With Liver or Gallbladder Cancer
Conditions: adult primary liver cancer; extrahepatic bile duct cancer; Gallbladder Cancer |
| 13. | | No longer recruiting | BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Conditions: recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ... |
| 14. | | Recruiting | BMS-247550 in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: recurrent grade 3 follicular lymphoma; recurrent adult diffuse large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
| 15. | | No longer recruiting | Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer |
| 16. | | No longer recruiting | Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers
Condition: unspecified adult solid tumor, protocol specific |
| 17. | | Recruiting | CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 18. | | No longer recruiting | Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: Leukemia; Lymphoma; Multiple Myeloma |
| 19. | | No longer recruiting | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer; Stage IV Melanoma; Recurrent Melanoma |
| 20. | | No longer recruiting | Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
Conditions: Gastrointestinal Cancer; Neck Cancer; Oral Cancer; Throat Cancer |
| 21. | | Recruiting | Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: adult solid tumor; Leukemia; Lymphoma |
| 22. | | No longer recruiting | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 23. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer
Conditions: transitional cell carcinoma of the bladder; stage IV bladder cancer |
| 24. | | No longer recruiting | Combination Chemotherapy Plus Augmerosen in Treating Patients With Untreated Extensive-Stage Small Cell Lung Cancer
Condition: extensive stage small cell lung cancer |
| 25. | | No longer recruiting | Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma
Conditions: stage III melanoma; Stage IV Melanoma; Recurrent Melanoma |
| 26. | | Recruiting | Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
Conditions: localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma; epithelial mesothelioma; ... |
| 27. | | Suspended | Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
Conditions: stage I melanoma; stage II melanoma; stage III melanoma; Stage IV Melanoma |
| 28. | | No longer recruiting | Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
Conditions: recurrent adult primary liver cancer; advanced adult primary liver cancer; cholangiocarcinoma of the gallbladder; ... |
| 29. | | Recruiting | Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer
Conditions: stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; ... |
| 30. | | Completed | Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma
Conditions: recurrent adult lymphoblastic lymphoma; recurrent adult immunoblastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ... |
| 31. | | Not yet recruiting | FR901228 in Treating Patients With Advanced Colorectal Cancer That Has Progressed After a Previous Fluorouracil-Containing Regimen
Conditions: recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; Stage IV rectal cancer |
| 32. | | Recruiting | FR901228 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 33. | | Not yet recruiting | FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer
Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
| 34. | | Recruiting | Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
Conditions: stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; Drug Toxicity |
| 35. | | Completed | Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
| 36. | | Recruiting | Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 37. | | Recruiting | Imatinib Mesylate in Treating Patients With Myelofibrosis
Conditions: Polycythemia Vera; chronic idiopathic myelofibrosis; Essential Thrombocythemia; Chronic Myelomonocytic Leukemia |
| 38. | | Suspended | Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer
Conditions: stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 39. | | Completed | Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Cancer |
| 40. | | No longer recruiting | Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer
Conditions: recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ... |
| 41. | | No longer recruiting | Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer
Condition: unspecified adult solid tumor, protocol specific |
| 42. | | Recruiting | Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 43. | | Completed | Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
Conditions: Leukemia; Lymphoma; Eye Cancer |
| 44. | | No longer recruiting | O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma
Conditions: stage IVB adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma |
| 45. | | No longer recruiting | O6-benzylguanine and Carmustine in Treating Patients with Unresectable Locally Recurrent or Metastatic Melanoma
Conditions: stage III melanoma; Stage IV Melanoma; Recurrent Melanoma |
| 46. | | Completed | O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery
Condition: unspecified adult solid tumor, protocol specific |
| 47. | | Recruiting | Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma; recurrent grade 3 follicular lymphoma |
| 48. | | No longer recruiting | Oxaliplatin in Treating Patients With Metastatic Bladder Cancer
Conditions: transitional cell carcinoma of the bladder; recurrent bladder cancer; stage IV bladder cancer; ... |
| 49. | | Completed | Oxaliplatin With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach
Conditions: stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ... |
| 50. | | No longer recruiting | Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
Conditions: stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ... |
